Fertility problems often plague people who have balanced chromosomal rearrangements. Such individuals are often healthy, but their chromosomes can pair incorrectly with partner chromosomes during meiosis, which can lead to chromosome abnormalities that, in turn, lead to miscarriage or children with congenital abnormalities.
Researchers have long been intrigued by the possibility that regions of DNA not directly affected by rearrangements are also subject to abnormalities including aneuploidy. Such an effect, called ICE (interchromosomal effect), has been observed in several studies, but other research suggests that it may not occur.
Samer Alfarawati and colleagues undertook a comprehensive examination of 283 newly fertilized oocytes and embryos from fertility clinics corresponding to 44 women carrying chromosome rearrangements. The researchers concluded that ICE does, indeed, occur. However, it happens at low frequency and only in early embryos from women with a certain type of translocation called a Robertsonian translocation.
Robertsonian translocations involve a group of chromosomes with tandem copies of ribosomal RNAs in their short arms, which help direct the chromosome to the nucleolus. These short arms are lost in the translocation, possibly resulting in the chromosomes being unable to associate with the nucleolus. The researchers speculate that ICE may occur only during the first few mitotic divisions following fertilization of the oocyte, since they observed ICE in early embryos of women with a Robertsonian translocation, but not in their oocytes. This is an unusual conclusion, as it is generally believed that most aneuploidy results from meiotic errors.
Even people with normal chromosomes have high rates of aneuploidy at the preimplantation stage; 64 percent of the early embryos from unaffected individuals had at least one aneuploid cell (blastomere), compared with 70 percent of embryos from Robertsonian translocation carriers. Out of every 11 euploid zygotes produced by a Robertsonian translocation carrier, one is expected to become abnormal at an early cleavage stage due to ICE, the authors concluded. As abnormal blastomeres may have the potential to be eliminated during the early cleavage stages, the ultimate impact of ICE on embryo health remains unclear.
Nonetheless, the researchers suggest that people with Robertsonian translocations undergo additional genetic counseling and that rigorous evaluation of early blastomeres by preimplantation genetic diagnosis should be considered. A daughter may be more like her mother than she thought. According to a new study, a woman's fertility may be associated with the age at which her mother began menopause.
Previous reports have shown an association between mothers' and daughters' ages at menopause, so J.G. Bentzen and colleagues asked whether the age at which a woman enters menopause correlates with the number of eggs remaining in her daughter's ovaries.
The researchers studied more than 500 Danish women aged 20-40 years and evaluated their fertility with two methods. First, they examined their serum concentration of anti-Mü llerian hormone (AMH), a hormone produced by growing ovarian follicles. AMH levels correlate with the number of viable eggs remaining in the ovary. Second, using ultrasound, the researchers measured the number of maturing ovarian follicles (antral follicles), the number of which has been shown to correlate with the ovarian reserve.
The subjects also self-reported the age at which their mothers began menopause, an event that is initiated at a range of ages in the population. About 13 percent of the mothers of these study subjects began menopause early (before age 45) and 15 percent began late (after age 55).
Bentzen and colleagues report that the age of maternal menopause did affect measurements of ovarian reserve. Women whose mothers had early menopause had the fastest declines in AMH and antral follicle count. AMH concentration, for instance, declined 8.6 percent per year in this group. Women whose mothers entered menopause late had the slowest decline: their AMH concentration declined by 3.2 percent per year.
The findings provide insight into the measures that can be used to predict and systematically assess a woman's ovarian reserve. The researchers are planning a five-year longitudinal study to help assess the combined value of markers of ovarian reserve, such as age, age of mother at menopause, AMH levels, and antral follicle count. Mutations in a relatively obscure protein in the human pituitary gland and testis appear to be behind a human syndrome involving reductions in thyroid hormone synthesis and enlarged testes.
IGSF1 (immunoglobulin superfamily, member 1) is a membraneassociated glycoprotein that is highly expressed in both the brain and the pituitary gland. Its function has not yet been discovered.
Daniel Bernard and an international team of researchers honed in on IGSF1 when studying families with an apparently similar X-linked syndrome. Boys and men with the syndrome had hypothyroidism and most had low concentrations of prolactin. Most boys' pubertal testosterone production and growth spurt were delayed, and more than half of the adults with the syndrome had an elevated body mass index. Affected males also had unusually large testes beginning around the age of 11.
The researchers traced these phenotypes to loss-of-function mutations in IGSF1 that impaired its trafficking to the cell membrane. To further assess how IGSF1 mutations would lead to this syndrome, the researchers examined mice deficient in Igsf1. The pituitary glands of these mice had reduced expression of the receptor for thryotropinreleasing hormone (TRH), a hormone that controls the production of thyroid hormones by activating thyroid-stimulating hormone (TSH). TSH likewise was at a low concentration in both the pituitary gland and the serum of these mice.
The researchers concluded that mutations in IGSF1 impair TRH signaling in the pituitary, leading to central hypothyroidism. Although there is an extensive body of data indicating that thyroid hormones regulate the proliferation of Sertoli cells, the reasons for the testicular enlargement remain unexplained. Future experiments will help determine how IGSF1 regulates TRH receptor expression and function in the pituitary gland. The cells of the early mammalian embryo are not all created equal. That is the conclusion of a study showing that fate of cells from 4-and 8-cell stage mouse embryos is not random; instead, individual cells are biased to give rise to either the trophectoderm or the inner cell mass, the two distinct cell populations that arise during the blastocyst stage.
It has long been known that all the early cleavage-stage blastomeres have the potential to give rise to either the trophectoderm, which becomes the placenta, or the inner cell mass, which develops into the fetus. More recent studies have refined this thinking: whereas each early blastomere is totipotent, there seems to be some bias in cell fate selection. For instance, as early as the 4-cell stage, some blastomeres can have elevated levels of methylation on the arginine residues of histone 3, indicative of an active chromatin state. Previous work has suggested that these cells are more likely to give rise to the inner cell mass.
The new study by Inna Tabansky et al. supports the view that, at least in a fraction of embryos, cell fate is nonrandom. They traced the lineage of each cell using a cell marking method first used to trace neuronal cell fate, which employs ''Rainbow'' transgenic mice. The method relies on the action of a Cre recombinase that turns on target transgenes, resulting in expression of various combinations of fluorescent proteins. The researchers ''marked'' the cells by activating the Cre recombinase at the 4-or 8-cell stage, examined the pattern of fluorescence at the blastocyst stage, and determined whether the pattern was likely to be the result of a random or nonrandom cell fate choice at the 4-or 8-cell stage.
In as many as 40 percent of the embryos, they could observe a bias in the contribution made by the marked clones to either the trophectoderm or the inner cell mass. The bias is relevant for subsequent development, since it persisted in embryos analyzed at the postimplantation stages.
This study may have implications for human assisted reproduction. In current procedures for preimplantation genetic diagnosis (PGD), a blastomere is removed from the embryo at the 8-cell stage. If human blastomeres at this stage have already acquired a bias toward a particular cell fate, it is theoretically possible that PGD may have an effect on subsequent development.
Many embryos seem to recover well after PGD and to date studies have shown no problems with the children born after this procedure. Nonetheless, further research in this area may allow the procedure to be performed more reliably.
